ZA971446B - Therapeutic composition. - Google Patents

Therapeutic composition.

Info

Publication number
ZA971446B
ZA971446B ZA9701446A ZA971446A ZA971446B ZA 971446 B ZA971446 B ZA 971446B ZA 9701446 A ZA9701446 A ZA 9701446A ZA 971446 A ZA971446 A ZA 971446A ZA 971446 B ZA971446 B ZA 971446B
Authority
ZA
South Africa
Prior art keywords
dosage form
ibuprofen
therapeutic composition
fever
bicarbonate
Prior art date
Application number
ZA9701446A
Other languages
English (en)
Inventor
Ian Ashley Price
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ZA971446B publication Critical patent/ZA971446B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9701446A 1996-02-21 1997-02-20 Therapeutic composition. ZA971446B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603699.1A GB9603699D0 (en) 1996-02-21 1996-02-21 Therapeutic composition

Publications (1)

Publication Number Publication Date
ZA971446B true ZA971446B (en) 1997-11-25

Family

ID=10789176

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9701446A ZA971446B (en) 1996-02-21 1997-02-20 Therapeutic composition.

Country Status (25)

Country Link
US (1) US20020034540A1 (enExample)
EP (1) EP0881899B1 (enExample)
JP (2) JP2000507922A (enExample)
KR (1) KR19990087084A (enExample)
CN (1) CN1215989A (enExample)
AT (1) ATE273696T1 (enExample)
AU (1) AU722991B2 (enExample)
BG (1) BG64165B1 (enExample)
CA (1) CA2246344C (enExample)
CZ (1) CZ298371B6 (enExample)
DE (1) DE69730314T2 (enExample)
DK (1) DK0881899T3 (enExample)
ES (1) ES2227670T3 (enExample)
GB (1) GB9603699D0 (enExample)
HU (1) HUP9901454A3 (enExample)
IL (1) IL125803A0 (enExample)
NO (1) NO983825L (enExample)
NZ (1) NZ331416A (enExample)
PL (1) PL187383B1 (enExample)
PT (1) PT881899E (enExample)
RU (1) RU2182000C2 (enExample)
SK (1) SK285032B6 (enExample)
UA (1) UA55407C2 (enExample)
WO (1) WO1997030699A2 (enExample)
ZA (1) ZA971446B (enExample)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955107A (en) * 1997-12-12 1999-09-21 Fmc Corporation Pharmaceutical suspension tablet compositions
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
NZ508292A (en) * 1999-11-24 2002-08-28 Mcneil Ppc Inc Treatment of migraine symptoms with ibuprofen and salts thereof
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
EP1379226A2 (en) * 2001-04-10 2004-01-14 Zagros Pharma Inc. Animal model for evaluating analgesics
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
JP2006521287A (ja) * 2002-12-20 2006-09-21 エスティ．ジェイムス アソシエイト エルエルシー／フェイバー リサーチ シリーズ 医薬製剤用の高圧圧縮
US20040176234A1 (en) * 2003-03-07 2004-09-09 Baker Hughes Incorporated Method for improving separation operation of centrifuges and associated improved separation designs
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
UY28583A1 (es) * 2003-10-30 2005-05-31 Roche Consumer Health Ag Forma de presentación del naproxeno sodico
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
EP3216445A1 (en) * 2004-05-28 2017-09-13 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
NZ552208A (en) * 2004-06-29 2008-11-28 Nycomed Danmark Aps Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
RU2389480C2 (ru) * 2004-08-12 2010-05-20 РЕКИТТ БЕНКАЙЗЕР ХЕЛТКЭА (Ю Кей) ЛИМИТЕД Гранулы, содержащие нпвлс и сахарный спирт, изготовленные экструзией из расплава
US20070077297A1 (en) 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
ZA200702694B (en) * 2004-09-30 2008-07-30 Scolr Pharma Inc Modified release ibuprofen dosage form
EP1817021A1 (en) * 2004-11-03 2007-08-15 Equitech Corporation Nsaid compositions exhibiting clinical superiority
PT1850834E (pt) * 2005-02-09 2014-10-27 Boehringer Ingelheim Int Comprimidos revestidos por um filme, contendo lisinato de ibuprofeno
US9205054B2 (en) 2005-03-22 2015-12-08 Losan Pharma Gmbh Solubilized ibuprofen
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
BRPI0617258A2 (pt) * 2005-09-19 2011-07-19 Albemarle Corparation soluções aquosas escoáveis altamente concentradas de ibuprofeno de potássio suas preparações e seus usos
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
KR101288924B1 (ko) * 2006-08-16 2013-07-24 에스에스 세야쿠 가부시키 가이샤 경구투여용 제제
FI20070521L (fi) 2006-11-10 2008-05-11 Atacama Labs Oy Rakeita, tabletteja ja rakeistusmenetelmä
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US7749537B2 (en) 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
WO2008079245A2 (en) * 2006-12-20 2008-07-03 Duramed Pharmaceuticals, Inc. Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
EP2291233B1 (en) * 2008-05-09 2019-09-04 Atacama Labs Oy Method for dry granulation
US9629809B2 (en) * 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
BRPI0916344A2 (pt) 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
WO2011001228A1 (en) * 2008-08-14 2011-01-06 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
TWI504393B (zh) * 2009-06-22 2015-10-21 Wyeth Llc 製備包含異丁苯丙酸鈉之醫藥組合物之方法
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
CN103102259B (zh) * 2011-12-23 2014-02-26 海南正瑞医药科技开发有限公司 一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
KR101890649B1 (ko) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 정제
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) * 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
KR102470283B1 (ko) 2014-07-02 2022-11-23 옵스에파 에스에이 결정질 (3z,5s)-5-(하이드록시메틸)-1-[(2'-메틸-1,1'-바이페닐-4-일)카르보닐]피롤리딘-3-온 o-메틸옥심
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
WO2017060920A1 (en) * 2015-10-05 2017-04-13 Strides Shasun Limited Pharmaceutical compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
DE3440288C2 (de) * 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
US4684666A (en) * 1986-08-19 1987-08-04 Haas Pharmaceuticals, Inc. Stabilized liquid analgesic compositions
JPH02500189A (ja) * 1986-10-22 1990-01-25 ジ・アップジョン・カンパニー イブプロフェンまたはフルルビプロフェンを用いる歯肉炎の治療
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US4837031A (en) * 1987-09-17 1989-06-06 Mallinckrodt, Inc. Compositions containing ibuprofen
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
SK279279B6 (sk) * 1991-05-13 1998-09-09 The Boots Company Plc S(-)-nátrium-2-(4-izobutylfenyl)propionát-dihydrát
DE4216756C2 (de) * 1992-05-21 1994-08-25 Pharmatrans Sanaq Ag 2-Arylpropionsäure-Zubereitungen und Verfahren zu ihrer Herstellung
ATE180668T1 (de) * 1992-12-01 1999-06-15 Spirig Ag S(+)-ibuprofen enthaltende arzneimittel

Also Published As

Publication number Publication date
US20020034540A1 (en) 2002-03-21
WO1997030699A2 (en) 1997-08-28
UA55407C2 (uk) 2003-04-15
WO1997030699A3 (en) 1997-10-09
PL187383B1 (pl) 2004-06-30
SK114298A3 (en) 1999-01-11
PT881899E (pt) 2004-12-31
HUP9901454A3 (en) 2001-04-28
BG102744A (bg) 1999-05-31
RU2182000C2 (ru) 2002-05-10
PL328465A1 (en) 1999-02-01
CN1215989A (zh) 1999-05-05
KR19990087084A (ko) 1999-12-15
JP2009073847A (ja) 2009-04-09
NO983825D0 (no) 1998-08-20
EP0881899B1 (en) 2004-08-18
CZ298371B6 (cs) 2007-09-12
NO983825L (no) 1998-10-20
IL125803A0 (en) 1999-04-11
CZ261798A3 (cs) 1998-11-11
GB9603699D0 (en) 1996-04-17
AU1793797A (en) 1997-09-10
JP2000507922A (ja) 2000-06-27
DK0881899T3 (da) 2004-12-20
DE69730314D1 (de) 2004-09-23
AU722991B2 (en) 2000-08-17
DE69730314T2 (de) 2005-08-18
NZ331416A (en) 2000-02-28
CA2246344A1 (en) 1997-08-28
HUP9901454A2 (hu) 1999-08-30
CA2246344C (en) 2009-01-20
SK285032B6 (sk) 2006-05-04
ATE273696T1 (de) 2004-09-15
BG64165B1 (bg) 2004-03-31
ES2227670T3 (es) 2005-04-01
EP0881899A2 (en) 1998-12-09

Similar Documents

Publication Publication Date Title
ZA971446B (en) Therapeutic composition.
US5782971B1 (en) Calcium phosphate cements comprising amorophous calcium phosphate
IL112518A0 (en) Thyroid hormone fast dispersing pharmaceutical composition
ZA899372B (en) Hemostatic collagen paste composition
CA2265766A1 (en) Rapidly disintegrating pellets
ES2046083A1 (es) Procedimiento para preparar composiciones de liberacion prolongada.
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
ZA949309B (en) Composition for the production of therapeutic products in vivo
NZ514077A (en) Treatment of Α-galactosidase A deficiency
ES2033196A1 (es) Granulos diospersables de productos fungicidas.
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
CA2284663A1 (en) Rapidly dissolving robust dosage form
CA2228295A1 (en) Cosmetic powder compositions having improved skin coverage
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
ES8303090A1 (es) Procedimiento para la obtencion de comprimidos medicionales de rapida disgregacion.
MY109531A (en) Effervescent antacid
CA2210321A1 (fr) Compositions pharmaceutiques sous forme de comprimes a liberation prolongee a base de granules en polysaccharides de haut poids moleculaire
EP0237241A3 (en) Calcium supplement compressed tablets
EP0367056A3 (en) A granulating composition and method
GB0300654D0 (en) Detergent compositions
HUT75228A (en) Process for preparing a clodronate preparation
ES2059260A1 (es) Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
SU1764213A1 (ru) Состав для предотвращения и тушения пожаров в замкнутых объемах
JPS5344617A (en) Drug composition
MD566C2 (ro) Procedeu de preparare a materialului plastic sclerosuspendator din ţesutul osos